• 2021
  Bakoa F, Préhaud C, Beauclair G, Chazal M, Mantel N, Lafon M, Jouvenet N, , Genomic diversity contributes to the neuroinvasiveness of the Yellow fever French neurotropic vaccine., NPJ Vaccines 2021 Apr; 6(1): 64.
• 2019
  Khan Z, Terrien E, Delhommel F, Lefebvre-Omar C, Bohl D, Vitry S, Bernard C, Ramirez J, Chaffotte A, Ricquier K, Vincentelli R, Buc H, Prehaud C, Wolff N, Lafon M, Structure-based optimization of a PDZ-binding motif within a viral peptide stimulates neurite outgrowth, J. Biol. Chem. 2019 Sep;294(37):13755-13768.
• 2019
  da Costa A, Prehaud C, Bakoa F, Afonso P, Ceccaldi PE, Lafaye P, Lafon M, , A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain., J Vis Exp 2019 04; (146): .
• 2015
  Caillet-Saguy C, Maisonneuve P, Delhommel F, Terrien E, Babault N, Lafon M, Cordier F, Wolff N, , Strategies to interfere with PDZ-mediated interactions in neurons: What we can learn from the rabies virus., Prog Biophys Mol Biol 2015 Oct; 119(1): 53-9.
• 2014
  Si-Tahar M, Blanc F, Furio L, Chopy D, Balloy V, Lafon M, Chignard M, Fiette L, Langa F, Charneau P, Pothlichet J, Protective role of LGP2 in influenza virus pathogenesis, J. Infect. Dis. 2014 Jul;210(2):214-23.
• 2012
  Cordier F, Chaffotte A, Terrien E, Préhaud C, Theillet FX, Delepierre M, Lafon M, Buc H, Wolff N, Ordered phosphorylation events in two independent cascades of the PTEN C-tail revealed by NMR, J. Am. Chem. Soc. 2012 Dec;134(50):20533-43.
• 2011
  Babault N, Cordier F, Lafage M, Cockburn J, Haouz A, Prehaud C, Rey FA, Delepierre M, Buc H, Lafon M, Wolff N, Peptides targeting the PDZ domain of PTPN4 are efficient inducers of glioblastoma cell death, Structure 2011 Oct;19(10):1518-24.
• 2011
  Chopy D, Detje CN, Lafage M, Kalinke U, Lafon M, The type I interferon response bridles rabies virus infection and reduces pathogenicity, J. Neurovirol. 2011 Aug;17(4):353-67.
• 2011
  Chopy D, Pothlichet J, Lafage M, Mégret F, Fiette L, Si-Tahar M, Lafon M, Ambivalent role of the innate immune response in rabies virus pathogenesis, J. Virol. 2011 Jul;85(13):6657-68.
• 2011
  Lafon M, Evasive strategies in rabies virus infection, Adv. Virus Res. 2011;79:33-53.
• 2009
  Ménager P, Roux P, Mégret F, Bourgeois JP, Le Sourd AM, Danckaert A, Lafage M, Préhaud C, Lafon M, Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies, PLoS Pathog. 2009 Feb;5(2):e1000315.
• 2009
  Terrien E, Simenel C, Prehaud C, Buc H, Delepierre M, Lafon M, Wolff N, 1H, 13C and 15N resonance assignments of the PDZ of microtubule-associated serine/threonine kinase 205 (MAST205) in complex with the C-terminal motif from the rabies virus glycoprotein, Biomol NMR Assign 2009 Jun;3(1):45-8.
• 2008
  Lafon M, Mégret F, Meuth SG, Simon O, Velandia Romero ML, Lafage M, Chen L, Alexopoulou L, Flavell RA, Prehaud C, Wiendl H, Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis, J. Immunol. 2008 Jun;180(11):7506-15.
• 2008
  Bréhin AC, Mouriès J, Frenkiel MP, Dadaglio G, Desprès P, Lafon M, Couderc T, Dynamics of immune cell recruitment during West Nile encephalitis and identification of a new CD19+B220-BST-2+ leukocyte population, J. Immunol. 2008 May;180(10):6760-7.
• 2006
  Mégret F, Prehaud C, Lafage M, Moreau P, Rouas-Freiss N, Carosella ED, Lafon M, Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections, Hum. Immunol. 2007 Apr;68(4):294-302.
• 2006
  Jackson AC, Rossiter JP, Lafon M, Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases, J. Neurovirol. 2006 Jun;12(3):229-34.
• 2006
  Lafon M, Megret F, Lafage M, Prehaud C, The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA, J. Mol. Neurosci. 2006;29(3):185-94.
• 2005
  Lafon M, Prehaud C, Megret F, Lafage M, Mouillot G, Roa M, Moreau P, Rouas-Freiss N, Carosella ED, Modulation of HLA-G expression in human neural cells after neurotropic viral infections, J. Virol. 2005 Dec;79(24):15226-37.
• 2005
  Préhaud C, Mégret F, Lafage M, Lafon M, Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon, J. Virol. 2005 Oct;79(20):12893-904.
• 2005
  Lafon M, Bat rabies–the Achilles heel of a viral killer?, Lancet 2005 Sep 10-16;366(9489):876-7.
• 2005
  Lafon M, Rabies virus receptors, J. Neurovirol. 2005 Feb;11(1):82-7.
• 2004
  Baloul L, Camelo S, Lafon M, Up-regulation of Fas ligand (FasL) in the central nervous system: a mechanism of immune evasion by rabies virus, J. Neurovirol. 2004 Dec;10(6):372-82.
• 2003
  Thoulouze MI, Lafage M, Yuste VJ, Kroemer G, Susin SA, Israel N, Lafon M, Apoptosis inversely correlates with rabies virus neurotropism, Ann. N. Y. Acad. Sci. 2003 Dec;1010:598-603.
• 2003
  Lay S, Préhaud C, Dietzschold B, Lafon M, Glycoprotein of nonpathogenic rabies viruses is a major inducer of apoptosis in human jurkat T cells, Ann. N. Y. Acad. Sci. 2003 Dec;1010:577-81.
• 2003
  Préhaud C, Lay S, Dietzschold B, Lafon M, Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis, J. Virol. 2003 Oct;77(19):10537-47.
• 2003
  Thoulouze MI, Lafage M, Yuste VJ, Baloul L, Edelman L, Kroemer G, Israel N, Susin SA, Lafon M, High level of Bcl-2 counteracts apoptosis mediated by a live rabies virus vaccine strain and induces long-term infection, Virology 2003 Sep;314(2):549-61.
• 2003
  Baloul L, Lafon M, Apoptosis and rabies virus neuroinvasion, Biochimie 2003 Aug;85(8):777-88.